Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Caught in the Act: NPC1 Found to Bind Cholesterol
23 August 2004. Neiman-Pick type C (NPC) disease intrigues Alzheimer's researchers for several reasons. For one thing, the neurodegenerative disorder involves tau hyperphosphorylation. For another, the two proteins that underlie the disease, NPC1 and NPC2, are clearly critical in cholesterol homeostasis in the brain, as evidenced by the dramatic buildup of neuronal cholesterol in NPC. Since there is at least some evidence that each of the APP secretases (α, β, and γ) is affected by alterations in cholesterol trafficking or concentration, a clearer understanding of cholesterol metabolism should also be useful for the β-amyloid side of Alzheimer's research.

In an article published August 16 in PNAS Early Edition, Ta-Yuan Chang's group at Dartmouth University in Hanover, New Hampshire, in collaboration with Matthew Scott's lab in Stanford University in California, reports that NPC1 binds cholesterol directly, and that sterol-sensing domains on the protein are necessary for this union.

NPC2 is a soluble lysosomal protein that clearly binds cholesterol with high affinity (see ARF related news story). However, only some 5 percent of NPC cases are due to mutations in the NPC2 gene. The remaining 95 percent of NPC cases can be blamed on a defect in NPC1, a lysosomal-endosomal transmembrane protein. While NPC1 is generally acknowledged to help guide cholesterol to appropriate intracellular compartments, there is only a circumstantial case that it binds cholesterol directly.

First author Nobutaka Ohgami and colleagues used photoaffinity labeling of intact cells to show NPC1 binding directly to the cholesterol analog 7,7-azocholestenol. This interaction does not require the assistance of NPC2, a possibility that has been suggested by some researchers. However, this binding does require that the sterol sensing domains of NPC1 be functional, as the authors demonstrated by severely reducing the binding with several different loss-of-function mutations in these domains. This latter finding suggests to the authors the possibility that other proteins involved in cholesterol-dependent regulatory events—and which possess sterol sensing domains (e.g., HMG-Coa reductase, SCAP, PATCHED, and NPC1L1)—may also bind sterols directly.—Hakon Heimer.

Reference:
Ohgami N, Ko DC, Thomas M, Scott MP, Chang CC, Chang TY. Binding between the Niemann-Pick C1 protein and a photoactivatable cholesterol analog requires a functional sterol-sensing domain. Binding between the Niemann-Pick C1 protein and a photoactivatable cholesterol analog requires a functional sterol-sensing domain. Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12473-8. Epub 2004 Aug 16. Abstract

 
Comments on News and Primary Papers
  Comment by:  Tobias Hartmann
Submitted 23 August 2004  |  Permalink Posted 24 August 2004

Fascinating and a clear milestone. This will most likely trigger the discovery of many more cholesterol sensing proteins and will greatly assist the understanding of the cell biology of the lipid-protein crossroads.

View all comments by Tobias Hartmann

  Comment by:  Inez Vincent, ARF Advisor
Submitted 30 August 2004  |  Permalink Posted 30 August 2004

Because of the accumulation of cholesterol in NPC patients having mutated NPC1, it has been assumed for many years that NPC1 is a cholesterol transporter. For the first time, the work of Ohgami et al. demonstrates a direct interaction between a cholesterol analog and NPC1 that requires the sterol-sensing domain of the protein. This is an important development in the field of NPC research. It opens the way to establishing similar functional interactions between other lipids and NPC1, and also NPC1-related proteins.

View all comments by Inez Vincent

  Comment by:  Dora M. Kovacs, ARF Advisor
Submitted 31 August 2004  |  Permalink Posted 31 August 2004

This is an interesting paper in the cholesterol field. I can only agree with Tobias and Inez Vincent that the identification of the NPC1 sterol-sensing domain as a possible binding site for cholesterol may lead to new clues for protein-lipid interactions.

View all comments by Dora M. Kovacs
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad